-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Immix Biopharma, Inc. annual/quarterly Share-based Payment Arrangement, Expense history and growth rate from 2021 to 2023.
- Immix Biopharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2023 was $178K, a 174% increase year-over-year.
- Immix Biopharma, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2023 was $590K, a 167% increase year-over-year.
- Immix Biopharma, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $731K, a 53.4% increase from 2022.
- Immix Biopharma, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $477K, a 198% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)